Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Phylum Tenericutes01:24

Bacterial Phylum Tenericutes

The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

225
The pathophysiology of pneumonia involves the following steps:
225
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

361
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
361

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial respiratory infections: advances in diagnostic strategies.

Expert review of molecular diagnostics·2026
Same author

Improving prediction of future Mycoplasma pneumoniae epidemics using data-driven transmission models.

The Lancet. Microbe·2026
Same author

Evaluation of the ELITe InGenius PCR assay compared with immunofluorescence for Pneumocystis jirovecii detection in respiratory samples.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Age-Specific Trends in the Prescription of Systemic Antibiotics, 2010-2024.

Deutsches Arzteblatt international·2026
Same author

<i>Waddlia chondrophila</i>: from a bovine abortigenic agent to a potential cause of human adverse pregnancy outcomes.

Journal of medical microbiology·2026
Same author

Beyond the Target: Re-Emergence of Mycoplasma pneumoniae Supports Reclassification of Adult Mucocutaneous Eruptions.

International journal of dermatology·2026

Related Experiment Video

Updated: Jun 9, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.3K

Mycoplasma pneumoniae: not a typical respiratory pathogen.

Richard S Rowlands1, Patrick M Meyer Sauteur2, Michael L Beeton1

  • 1Microbiology and Infection Research Group, Department of Biomedical Sciences, Cardiff Metropolitan University, Western Avenue, Cardiff. CF5 2YB, UK.

Journal of Medical Microbiology
|October 30, 2024
PubMed
Summary

Mycoplasma pneumoniae causes pneumonia in children and young adults, with epidemic cycles linked to immunity and variant shifts. Antibiotic resistance and vaccine challenges hinder effective treatment and prevention strategies.

Keywords:
CARDS toxinP1 typeadhesionatypical pneumoniaextrapulmonary diseasemacrolidesvaccine-enhanced disease

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.4K

Related Experiment Videos

Last Updated: Jun 9, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.4K

Area of Science:

  • * Infectious Diseases
  • * Microbiology
  • * Pediatrics

Background:

  • * Mycoplasma pneumoniae is a primary cause of community-acquired pneumonia in school-aged children and young adults.
  • * Infections exhibit seasonal surges, particularly in winter, with epidemic cycles occurring every 1-4 years.
  • * Previously considered low virulence, M. pneumoniae possesses significant virulence factors, including toxin production and immune evasion mechanisms.

Purpose of the Study:

  • * To review the epidemiology, virulence, and challenges in treating and preventing Mycoplasma pneumoniae infections.
  • * To highlight the growing concern of macrolide resistance and the complexities of vaccine development.

Main Methods:

  • * Literature review of existing studies on Mycoplasma pneumoniae.
  • * Analysis of epidemiological data, virulence factors, treatment limitations, and vaccine research.

Main Results:

  • * M. pneumoniae infections are characterized by epidemic cycles influenced by immunity and circulating variants.
  • * The organism's lack of a cell wall and reduced metabolism restrict antibiotic treatment options.
  • * Acquired macrolide resistance is a significant issue, particularly in certain regions, and vaccine development faces hurdles like vaccine-enhanced disease.

Conclusions:

  • * Effective management of M. pneumoniae requires addressing antibiotic resistance and understanding immune dynamics.
  • * Further research is needed to overcome challenges in developing safe and effective vaccines against M. pneumoniae pneumonia.